A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis

NCT02985593 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Men and Subjects With Ulcerative Colitis

Interventions

DRUG: KHK4083
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.